IGFBP2 and pulmonary hypertension: These findings suggest a consistent association between sPAP and IGF-BP2 levels throughout different stages of assessment, indicating a potential role of IGF-BP2 in the pathophysiology of pulmonary hypertension in severe aortic valve stenosis patients.